Cargando…

Efficacy and Safety of Cystatin C-Guided Renal Dose Adjustment of Cefepime Treatment in Hospitalized Patients with Pneumonia

Cystatin C (CysC) may estimate renal function more accurately than serum creatinine (SCr). The clinical impact of renal dose adjustment of cefepime according to CysC rather than SCr has remained uncertain. We investigated the efficacy and safety of CysC-guided cefepime dosing compared with SCr-guide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Min-Chul, Kim, Seon Ok, Kim, Su-Hyun, Shin, Jung-ho, Choi, Seong-Ho, Chung, Jin-Won, Hwang, Jin Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7564664/ https://www.ncbi.nlm.nih.gov/pubmed/32872649 http://dx.doi.org/10.3390/jcm9092803

Ejemplares similares

Cefepime Neurotoxicity in Patients with Renal Insufficiency
por: Kim, Seon-Yu, et al.
Publicado: (2012)

New Onset Non-Convulsive Status Epilepticus Despite Cefepime Renal Dose Adjustment
por: Oyenuga, Mosunmoluwa, et al.
Publicado: (2021)

Usefulness of serum cystatin C to determine the dose of vancomycin in neonate
por: Shin, Jeong Eun, et al.
Publicado: (2015)

Comparison of Cefepime with Piperacillin/Tazobactam Treatment in Patients with Hospital-Acquired Pneumonia
por: Kim, Bo-Guen, et al.
Publicado: (2023)

A New Equation to Estimate Muscle Mass from Creatinine and Cystatin C
por: Kim, Sun-wook, et al.
Publicado: (2016)

1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment
por: Geibel, Brooke, et al.
Publicado: (2020)

Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine
por: Park, Ji Young, et al.
Publicado: (2021)

Utility of Magnetic Resonance Imaging for Differentiating Necrotizing Fasciitis from Severe Cellulitis: A Magnetic Resonance Indicator for Necrotizing Fasciitis (MRINEC) Algorithm
por: Kim, Min-Chul, et al.
Publicado: (2020)

Calf Circumference as an Indicator for Cystatin C Testing in Hospitalized Elderly Male Patients for Detecting Hidden Renal Impairment
por: Lee, Sunghwan, et al.
Publicado: (2023)

Cefepime: Cefepime-induced encephalopathy: case report
Publicado: (2022)

Cefepime-induced encephalopathy with normal renal function
por: Meillier, Andrew, et al.
Publicado: (2016)

Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study
por: Su, Ting-Yi, et al.
Publicado: (2017)

Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
por: Kim, Dong Jin, et al.
Publicado: (2011)

Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment
por: Cho, Su-Hee, et al.
Publicado: (2019)

Clinical and radiological findings of adult hospitalized patients with community-acquired pneumonia from SARS-CoV-2 and endemic human coronaviruses
por: Baek, Moon Seong, et al.
Publicado: (2021)

Clinical Usefulness of Serum Cystatin C as a Marker of Renal Function
por: Woo, Kwang-Sook, et al.
Publicado: (2014)

Cefepime-Induced Non-Convulsive Status Epilepticus in a Patient with Normal Renal Function
por: Park, Hyeon-Mi, et al.
Publicado: (2016)

Spot Urine Albumin to Creatinine Ratio and Serum Cystatin C are Effective for Detection of Diabetic Nephropathy in Childhood Diabetic Patients
por: Chae, Hyun-Wook, et al.
Publicado: (2012)

Cefepime- Induced Non-Convulsive Status Epilepticus (NCSE)
por: Kim, Ahro, et al.
Publicado: (2013)

The Efficacy of the Cystatin C Based Glomerular Filtration Rate in the Estimation of Safe Contrast Media Volume
por: Yoon, Hyuck-Jun, et al.
Publicado: (2013)

Eosinophilic pneumonia caused by cefepime: A case report and review
por: Jones, Bruce M., et al.
Publicado: (2021)

Cystatin-C is associated with partial recovery of kidney function and progression to chronic kidney disease in living kidney donors: Observational study
por: Bang, Ji-Yeon, et al.
Publicado: (2017)

Serum Cystatin C Reflects the Progress of Albuminuria
por: Yoo, Jeong Seon, et al.
Publicado: (2011)

Immune Responses against the Omicron Variant of SARS-CoV-2 after a Third Dose of COVID-19 Vaccine in Patients Living with Human Immunodeficiency Virus (PLWH): Comparison with Healthcare Workers
por: Park, Joung Ha, et al.
Publicado: (2022)

Acute Kidney Injury Adjusted for Parenchymal Mass Reduction and Long-Term Renal Function after Partial Nephrectomy
por: Yoon, Hyun-Kyu, et al.
Publicado: (2019)

Establishment of muscle mass-based indications for the cystatin C test in renal function evaluation
por: Yim, Jisook, et al.
Publicado: (2022)

1228. Outcomes Associated with Empiric Cefepime or Meropenem for Bloodstream Infections Caused by Ceftriaxone-Resistant, Cefepime-Susceptible Escherichia coli and Klebsiella pneumoniae
por: Frescas, Brian E, et al.
Publicado: (2021)

Population Pharmacokinetics and Monte Carlo Simulation of Cefepime in Critically Ill Patients with Hospital-Acquired/Ventilator-Associated Pneumonia
por: Seo, Hyeonji, et al.
Publicado: (2023)

Cefepime Dosing Requirements in Elderly Patients Attended in the Emergency Rooms
por: Ruiz-Ramos, Jesus, et al.
Publicado: (2022)

Cefepime-Induced Encephalopathy in a Tertiary Medical Center in Korea
por: Jeon, Ji-Ye, et al.
Publicado: (2020)

Comparison of the Impact of High-Flux Dialysis on Mortality in Hemodialysis Patients with and without Residual Renal Function
por: Kim, Hyung Wook, et al.
Publicado: (2014)

In vivo pharmacokinetic/pharmacodynamic evaluation of cefepime/taniborbactam combination against cefepime-non-susceptible Enterobacterales and Pseudomonas aeruginosa in a murine pneumonia model
por: Abdelraouf, Kamilia, et al.
Publicado: (2023)

Higher Prevalence of Klebsiella pneumoniae Extended-Spectrum β-Lactamase in Patients on Renal Replacement Therapy
por: Lee, Hyang-Lim, et al.
Publicado: (2013)

Serum Cystatin C is a Potential Endogenous Marker for the Estimation of Renal Function in Male Gout Patients with Renal Impairment
por: Choe, Jung-Yoon, et al.
Publicado: (2010)

Cefepime-induced encephalopathy
por: Kenzaka, Tsuneaki, et al.
Publicado: (2018)

Cefepime-Induced Encephalopathy
por: Keerty, Dinesh, et al.
Publicado: (2021)

Cefepime-Induced Neurotoxicity
por: Saini, Tanjot, et al.
Publicado: (2021)

Cefepime-Induced Delirium
por: Somoza-Cano, Francisco J, et al.
Publicado: (2021)

Cefepime-induced neurotoxicity in critically ill patients undergoing continuous renal replacement therapy: beware of dose reduction!
por: Honore, Patrick M., et al.
Publicado: (2015)

2258. Correlation of Electroencephalogram Findings and Dose Relative to Renal Function among Patients with Possible Cefepime-Induced Encephalopathy
por: Pettit, Natasha N, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_667q7kth32ghmaq23r2jmjgelo